Join
Live feed
·
PRReleasevia Quantisnow
Arvinas Inc. logo

Arvinas Joins The Michael J. Fox Foundation's LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson's Disease

ByQuantisnow·Wall Street's wire, on your screen.
ARVN· Arvinas Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARVN (Arvinas Inc.) and more on Quantisnow.